Επιλογή Σελίδας
Σεπ 14, 2015 | Announcements, Medical News, Scientific articles
By Patricia Silva, PhD Gilead Sciences, Inc. recently announced the publication of data in The New England Journal of Medicine concerning the AMBITION trial evaluating the combination therapy of Letairis® (ambrisentan) and tadalafil for pulmonary arterial...Σεπ 12, 2015 | Announcements, Medical News, Scientific articles
By Maureen Newman The recent announcement of positive results for the AMBITION trial testing combinatorial ambrisentan and tadalafil in patients with pulmonary arterial hypertension (PAH) is bringing more attention to the need to actively recruit participants for...Σεπ 10, 2015 | Announcements, Medical News, Scientific articles
By Patricia Inacio, PhD In a new study entitled “Symptom Interference Severity and Health-Related Quality of Life in Pulmonary Arterial Hypertension,” researchers determined which symptoms experienced by those with pulmonary arterial hypertension are the most...Σεπ 9, 2015 | Announcements, Medical News, Scientific articles
By Christine Traxler, MD An 18 year-long prospective study on the length of television watching and the risk of pulmonary embolism revealed a positive correlation between the length of time a person watches television per day and the risk of developing a possibly...Σεπ 8, 2015 | Announcements, Medical News, Scientific articles
By Christine Traxler, MD It was once thought among doctors that patients with pulmonary hypertension, many of whom can’t even walk a short distance without being short of breath, shouldn’t exercise. Pulmonary hypertension is a disease that leads to high blood...Ιούλ 25, 2013 | Medical News
Dr. Wendy Chung explains a graphic depicting a cross section of a potassium channel in a smooth muscle cell of the pulmonary artery. A study by Dr. Chung has identified six new mutations in a gene called KCNK3 that can interfere with the function of potassium channels...
Join our mailing list to receive the latest news and updates from our team.